Literature DB >> 7418480

Chest physical therapy. The immediate effect on oxygenation in acutely ill patients.

A F Connors, W E Hammon, R J Martin, R M Rogers.   

Abstract

There is no documentation in the literature of the risk of hypoxemia after chest percussion in acutely ill adults with nonsurgical pulmonary disorders. We studied the immediate effect of postural drainage and chest percussion (PDP) on oxygenation in 22 hospitalized patients with a variety of acute, nonsurgical pulmonary disorders. Heart rate, respiratory rate, blood pressure, and arterial blood gas levels were measured at four points before, during, and after PDP. There was a significant fall in PaO2 after chest percussion in ten patients who produced no sputum or small amounts of mucoid sputum. The mean PaO2 fell 16.8 mm Hg (P < 0.05) immediately after PDP, when compared to the value obtained after postural drainage alone, and had fallen another 5.3 mm Hg (P < 0.01) 30 minutes after return to the pretreatment position. There was no significant change in PaO2 in 12 patients who produced moderate to large amounts of mucopurulent secretions. The fall in PaO2 was probably due to increased ventilation-perfusion mismatch since this fall was avoided in two patients restudied while receiving 100 percent oxygen. We concluded that all acutely ill patients receiving PDP should be carefully monitored and, if necessary, should receive increased levels of inspired oxygen to avoid hypoxemia. Our data suggest that the use of PDP in patients without sputum production is not indicated and is potentially dangerous.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7418480     DOI: 10.1378/chest.78.4.559

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Thoracic percussion yields reversible mechanical changes in healthy subjects.

Authors:  Fernando S Guimarães; Walter A Zin
Journal:  Eur J Appl Physiol       Date:  2008-06-27       Impact factor: 3.078

Review 2.  Chest physiotherapy.

Authors:  D S Selsby
Journal:  BMJ       Date:  1989-03-04

3.  Hypoxaemia during chest physiotherapy in patients with cystic fibrosis.

Authors:  T McDonnell; W T McNicholas; M X FitzGerald
Journal:  Ir J Med Sci       Date:  1986-10       Impact factor: 1.568

4.  Effect of chest physical therapy on the prevention of atelectasis in children following cardiac surgery.

Authors:  C F McCarthy; J A DeCesare; J K Widell
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

5.  Maximum expiratory airflow during chest physiotherapy on ventilated patients before and after the application of an abdominal binder.

Authors:  D MacLean; G Drummond; C Macpherson; G McLaren; R Prescott
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

Review 6.  Chest physiotherapy for pneumonia in adults.

Authors:  Xiaomei Chen; Jiaojiao Jiang; Renjie Wang; Hongbo Fu; Jing Lu; Ming Yang
Journal:  Cochrane Database Syst Rev       Date:  2022-09-06

7.  Chest physiotherapy fails to prevent postoperative atelectasis in children after cardiac surgery.

Authors:  H D Reines; R M Sade; B F Bradford; J Marshall
Journal:  Ann Surg       Date:  1982-04       Impact factor: 12.969

8.  Chest physiotherapy prolongs duration of ventilation in the critically ill ventilated for more than 48 hours.

Authors:  Maie Templeton; Mark G A Palazzo
Journal:  Intensive Care Med       Date:  2007-07-03       Impact factor: 17.440

9.  The acute effects of body position strategies and respiratory therapy in paralyzed patients with acute lung injury.

Authors:  K Davis; J A Johannigman; R S Campbell; A Marraccini; F A Luchette; S B Frame; R D Branson
Journal:  Crit Care       Date:  2000-01-29       Impact factor: 9.097

10.  Evaluation of the effectiveness of manual chest physiotherapy techniques on quality of life at six months post exacerbation of COPD (MATREX): a randomised controlled equivalence trial.

Authors:  Jane L Cross; Frances Elender; Gary Barton; Allan Clark; Lee Shepstone; Annie Blyth; Max O Bachmann; Ian Harvey
Journal:  BMC Pulm Med       Date:  2012-07-02       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.